Literature DB >> 24805971

Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials?

Mark S Cary1, Jonathan D Rubright, Joshua D Grill, Jason Karlawish.   

Abstract

OBJECTIVES: Most Alzheimer disease (AD) caregivers are not spouses and yet most AD dementia trials enroll spousal study partners. This study examines the association between caregiver relationship to the patient and willingness to enroll in an AD clinical trial and how caregiver burden and research attitudes modify willingness.
DESIGN: Interviews with 103 AD caregivers who met criteria for ability to serve as a study partner.
RESULTS: A total of 54% of caregivers were spouses or domestic partners and the remaining were adult children. Willingness to enroll a patient in a clinical trial was associated with being a spouse [odds ratio (OR)=2.53, P=0.01], increasing age (OR=1.39, P=0.01), and increasing scores on the Research Attitudes Questionnaire (OR=1.39, P<0.001). No measures of caregiver burden or patient health were significant predictors of willingness. In multivariate models both research attitudes (OR=1.37, P<0.001) and being a spouse, as opposed to an adult child, (OR=2.06, P=0.048) were independently associated with willingness to participate.
CONCLUSIONS: Spousal caregivers had both a higher willingness to participate and a more positive attitude toward research. Caregiver burden had no association with willingness to participate. The strongest predictor of willingness was research attitudes.

Entities:  

Mesh:

Year:  2015        PMID: 24805971      PMCID: PMC4223007          DOI: 10.1097/WAD.0000000000000047

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  18 in total

1.  Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial.

Authors:  Jason H T Karlawish; David J Casarett; Bryan D James
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

2.  How do AD patients and their caregivers decide whether to enroll in a clinical trial?

Authors:  J H Karlawish; D Casarett; J Klocinski; P Sankar
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

3.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

4.  Effect of early patient enrollment on the time to completion and publication of randomized controlled trials.

Authors:  A B Haidich; J P Ioannidis
Journal:  Am J Epidemiol       Date:  2001-11-01       Impact factor: 4.897

5.  Clinical research participation among aging adults enrolled in an Alzheimer's Disease Center research registry.

Authors:  Angela L Jefferson; Susan Lambe; Christine Chaisson; Joseph Palmisano; Kathy J Horvath; Jason Karlawish
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Measuring how people view biomedical research: Reliability and validity analysis of the Research Attitudes Questionnaire.

Authors:  Jonathan D Rubright; Mark S Cary; Jason H Karlawish; Scott Y H Kim
Journal:  J Empir Res Hum Res Ethics       Date:  2011-03       Impact factor: 1.742

7.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

Authors:  D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

8.  Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease.

Authors:  Richard C Mohs; Claudia Kawas; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2006-07       Impact factor: 21.566

9.  Effect of study partner on the conduct of Alzheimer disease clinical trials.

Authors:  Joshua D Grill; Rema Raman; Karin Ernstrom; Paul Aisen; Jason Karlawish
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

10.  The continuing unethical conduct of underpowered clinical trials.

Authors:  Scott D Halpern; Jason H T Karlawish; Jesse A Berlin
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  20 in total

1.  Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout.

Authors:  Shana D Stites; R Scott Turner; Jeanine Gill; Anna Gurian; Jason Karlawish; Joshua D Grill
Journal:  Clin Trials       Date:  2021-01-10       Impact factor: 2.486

2.  Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role.

Authors:  Betty S Black; Holly A Taylor; Peter V Rabins; Jason Karlawish
Journal:  Dementia (London)       Date:  2016-05-13

3.  A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners.

Authors:  Chelsea G Cox; Mary M Ryan B A; Daniel L Gillen; Joshua D Grill
Journal:  Am J Geriatr Psychiatry       Date:  2018-11-03       Impact factor: 4.105

4.  Frequency and impact of informant replacement in Alzheimer disease research.

Authors:  Joshua D Grill; Yan Zhou; Jason Karlawish; David Elashoff
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

5.  Gamete and embryo donation for research: what might shape the willingness to donate among gamete donors and recipients?

Authors:  Sandra Pinto da Silva; Cláudia de Freitas; Milton Severo; Susana Silva
Journal:  J Assist Reprod Genet       Date:  2022-08-20       Impact factor: 3.357

6.  You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.

Authors:  Emily A Largent; Twisha Bhardwaj; Justin T Clapp; Olivia Saúl Sykes; Kristin Harkins; Joshua D Grill
Journal:  J Alzheimers Dis       Date:  2022-03-18       Impact factor: 4.160

7.  Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial.

Authors:  Navneet R Hakhu; Daniel L Gillen; Joshua D Grill
Journal:  Alzheimer Dis Assoc Disord       Date:  2022-04-29       Impact factor: 2.357

8.  Ethnoracial Differences in Lewy Body Diseases with Cognitive Impairment.

Authors:  Andrea M Kurasz; Glenn E Smith; Maria G McFarland; Melissa J Armstrong
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Recruiting Persons with Dementia and Caregivers in a Clinical Trial: Dyads Perceptions.

Authors:  Miranda V McPhillips; Darina V Petrovsky; Glenna S Brewster; Junxin Li; Nalaka S Gooneratne; Nancy A Hodgson; Justine S Sefcik
Journal:  West J Nurs Res       Date:  2021-04-17       Impact factor: 1.774

10.  Tailoring Research Recruitment for Acute Care Settings: Recommendations from People with Dementia and their Caregivers.

Authors:  Amanda M Friz; Clark Benson; Shannon Mullen; Laura Block; Andrea Gilmore-Bykovskyi
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jul-Sep 01       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.